Altimmune Shareholders Approve All AGM Proposals, Boost Authorized Shares to 400M

Altimmune (NASDAQ: ALT) shareholders approved all proposals presented at the company's virtual annual meeting on April 16, 2026, including the election of nine directors and amendments that expand the company's authorized common stock and employee stock purchase plan share reserve. Meeting format and attendance Jerome Durso, Chairman of the Board, called the meeting to order and